Guidance

Guidance on pharmacovigilance procedures

This guidance summarises our approach to pharmacovigilance

Published 31 December 2020
Last updated 29 January 2021 — see all updates
From:
Medicines and Healthcare products Regulatory Agency

Documents

Guidance on pharmacovigilance procedures

HTML

Details

See Exceptions and modifications to the EU guidance on good pharmacovigilance practices that will apply to UK MAHs and the MHRA

Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020. This webinar was part of a series of Brexit and post-transition guidance webinars:

Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020:

Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 22 October 2020:

Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 22 October 2020.

Published 31 December 2020
Last updated 29 January 2021 + show all updates

  1. New video entry - Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020

  2. Updated section 2 to include a list of reports received via the EMA from the 28 December to the 31 December

  3. First published.